NEW YORK--(BUSINESS WIRE)--Claryx, a genomic intelligence company, came out of stealth today with $3.5 million in pre-seed funding led by Outlander VC. It's building an immune system for hospitals, one that catches transmission while it's happening, shows the infection prevention team where to intervene, and confirms afterward that it stopped. Claryx was founded by brothers Kurt and Dirk Hackenberger, and it began with their grandmother. In 2004 she went in for a routine procedure, developed C.